BriaCell Therapeutics share price logo

BriaCell Therapeutics

NASDAQ: BCTX

$4.32

+0.04

(+0.82%)

as on

BriaCell Therapeutics Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.18
    $4.37
    downward going graph

    3.24%

    Downside

    1.16%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.60
    $14.68
    downward going graph

    39.81%

    Downside

    239.81%

    Upside

    downward going graph

BriaCell Therapeutics share price movements today

Previous Close
$4.28
Open
$4.36
Volume
224.1K
Market Cap
$37.2M
Day's Low - High
$4.18 - $4.37
52 Week Low - High
$2.60 - $14.68

BriaCell Therapeutics Historical Returns

1 Month Return
+ 7.07 %
3 Month Return
+ 41.01 %
1 Year Return
-60.91 %
3 Year Return
-99.48 %
5 Year Return
-99.69 %

BriaCell Therapeutics Stock Fundamentals & Key Indicators

Check BriaCell Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$37.2M

EPS (TTM)

-12.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.35

Industry PE ratio

-2.65

PEG Ratio

-0.0015438420106678398

EBITDA

-31.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-147.92%

BriaCell Therapeutics Stock Valuation

Track how BriaCell Therapeutics P/E has moved over time to understand its valuation trends.

BriaCell Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-25621.43x)

July 31, 2024

Industry (-2.65x)

July 31, 2025

Today (-0.16x)

July 31, 2025

Highest (-0.16x)

July 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.16x

BriaCell Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BriaCell Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BriaCell Therapeutics image
BriaCell Therapeutics
Buy$37.2M-99.69%-0.350.00%0.00%
Moderna image
Moderna
Neutral$77.8B-53.76%-24.41-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.4B186.58%30.1686.04%0.00%
Regeneron image
Regeneron
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for BriaCell Therapeutics Stock including INR - Dollar returns

The BriaCell Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

BriaCell Therapeutics investment value today

Current value as on today

₹42,282

Returns

-₹57,718

(-57.72%)

Returns from BriaCell Therapeutics Stock

-₹60,870 (-60.87%)

Dollar Impact

₹3,152 (+3.15%)

Analyst Recommendation on BriaCell Therapeutics Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for BriaCell Therapeutics. Average target price of $150

BriaCell Therapeutics Share Price Target

Get share price movements and forecasts by analysts on BriaCell Therapeutics.

What analysts predicted

97.12%UPSIDE

Target Price

$150

Current Price

$4.32

Analyzed by

5 Analysts

Target

$150.00

BriaCell Therapeutics target price $150, a slight upside of 97.12% compared to current price of $4.32. According to 5 analysts rating.

Indian Investors' Interest in BriaCell Therapeutics Stock

Search interest for BriaCell Therapeutics Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-37% versus previous 30 day period

BriaCell Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
0
-
-
-
Operating Income
-9
-
-5
-5
-7
-6
-8
-8
-7
-7
EBITDA
-9
-9
-5
-5
-7
-6
-8
-8
-7
-7
Interest Expense
-
-
-
-
-
0
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
1
-1
-5
-6
-6
-8
-8
-7
-7
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-11
1
-1
-5
-6
-6
-8
-8
-7
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

BriaCell Therapeutics Annual Profit & Loss

All numbers in Millions USD

Jul 2017
Jul 2018
Jul 2019
Jul 2021
Jul 2022
Jul 2023
Jul 2024
Jul 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
0
Operating Income
-3
-4
-6
-7
-15
-23
-33
-27
EBITDA
-3
-4
-6
-7
-26
-23
-4
-27
Interest Expense
-
0
0
0
0
-
-
0
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
-3
-5
-5
-13
-26
-20
-4
-26
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-3
-5
-5
-13
-26
-20
-4
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

BriaCell Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Net Income
-11
1
-1
-5
-6
-6
-8
-8
-7
-7
Operating Cash Flow
-7
-4
-4
-6
-5
-7
-8
-7
-7
-7
Investing Cash Flow
-
0
0
0
0
0
-7
0
7
-16
Financing Cash Flow
-
-
4
11
5
14
13
-
27
0
Change in Cash
-7
-5
0
4
0
7
-1
-7
27
-23

BriaCell Therapeutics Annual Cash Flow

All numbers in Millions USD

Jul 2017
Jul 2018
Jul 2019
Oct 2020
Jul 2021
Jul 2022
Jul 2023
Jul 2024
Jul 2025
Net Income
-3
-5
-5
-4
-13
-26
-20
-4
-26
Operating Cash Flow
-1
-4
-5
-1
-7
-12
-23
-24
-28
Investing Cash Flow
0
0
1
-
-
-
-
0
-7
Financing Cash Flow
2
5
2
1
64
-3
3
4
46
Change in Cash
1
0
0
0
57
-16
-19
-20
9

Global Institutional Holdings in BriaCell Therapeutics

Funds
Holdings
Group One Trading, LLC
0%
Susquehanna International Group, LLP
0%
Caitong International Asset Management Co., Limited.
0%
Sabby Management LLC
0.85%
BlackRock Inc
0%
See all

BriaCell Therapeutics News & Key Events

    Insights on BriaCell Therapeutics

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, BCTX stock has moved up by 7.1%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 202.2%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 773.0%

    About BriaCell Therapeutics

    BriaCell Therapeutics Corp. is a biotechnology company focused on immuno-oncology, dedicated to developing innovative immune-based therapies for cancer treatment. Its primary therapeutic candidate, Bria-IMT, is a whole-cell cancer vaccine currently undergoing Phase I/IIa clinical trials, where it is being evaluated in combination with the investigational immunotherapy retifanlimab. The company's pipeline also includes Bria-OTS, an accessible, personalized immunotherapy for advanced breast cancer, and BriaDx, a diagnostic test designed to determine patients' HLA types. BriaCell has established a non-exclusive clinical trial collaboration with Incyte Corporation to assess the effects of combining novel therapeutic candidates. Additionally, it holds a cooperative research and development agreement with the National Cancer Institute for preclinical studies to advance and test Bria-OTS cellular immunotherapy as a cancer treatment. The company's headquarters are situated in West Vancouver, Canada.
    OrganisationBriaCell Therapeutics
    HeadquartersBellevue Centre, West Vancouver, BC, V7T 2X1, CA
    IndustryBiotechnology
    CEOWilliam V. Williams
    E-voting on sharesClick here to vote

    Key Management of BriaCell Therapeutics

    Name

    Title

    Dr. William V. Williams FCPA, M.D.

    CEO, President & Director

    Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.

    CFO & Corporate Secretary

    Dr. Miguel A. Lopez-Lago Ph.D.

    Chief Scientific Officer

    Dr. Giuseppe Del Priore M.D., M.P.H.

    Chief Medical Officer

    Dr. Charles Louis Wiseman FACP, M.D.

    Founder, Principal Research Advisor & Member of Scientific Advisory Board

    FAQs

    What is BriaCell Therapeutics share price today?

    BriaCell Therapeutics share price today is $4.32 as on at the close of the market. BriaCell Therapeutics share today touched a day high of $4.37 and a low of $4.18.

    What is the 52 week high and 52 week low for BriaCell Therapeutics share?

    BriaCell Therapeutics share touched a 52 week high of $14.68 on and a 52 week low of $2.60 on . BriaCell Therapeutics stock price today i.e. is closed at $4.32,which is 70.57% down from its 52 week high and 66.15% up from its 52 week low.

    What is BriaCell Therapeutics's market capitalisation today?

    BriaCell Therapeutics market capitalisation is $0.00T as on .

    How to invest in BriaCell Therapeutics Stock (BCTX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for BriaCell Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BriaCell Therapeutics Shares that will get you 0.3472 shares as per BriaCell Therapeutics share price of $4.32 per share as on September 26, 2026 at 8:46 am IST.

    What is the minimum amount required to buy BriaCell Therapeutics Stock (BCTX) from India?

    Indian investors can start investing in BriaCell Therapeutics (BCTX) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹958.20 in BriaCell Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on BriaCell Therapeutics share’s latest price of $4.32 as on September 26, 2026 at 8:46 am IST, you will get 2.3148 shares of BriaCell Therapeutics. Learn more about fractional shares .

    What are the returns that BriaCell Therapeutics has given to Indian investors in the last 5 years?

    BriaCell Therapeutics stock has given -99.69% share price returns and 29.7% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?